ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,155Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 609

$535K Total Retail Price of All Prescriptions

Rank: 78 out of 609

331 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 331 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

8% of this provider’s 331 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 7,660 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 36%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
WARFARIN SODIUM 299 293 1 8
FUROSEMIDE 221 213 2 4
AMLODIPINE BESYLATE 213 189 3 2
METOPROLOL TARTRATE 198 188 4 9
NAMENDA 196 196 5 36
SIMVASTATIN 192 168 6 1
ZOLPIDEM TARTRATE 174 167 7 18
OMEPRAZOLE 160 154 8 3
LEVOTHYROXINE SODIUM 132 124 9 7
METFORMIN HCL 114 113 10 10
EXELON 112 112 11 142
MIRTAZAPINE 112 101 11 58
NYSTATIN 105 104 13 260
DONEPEZIL HCL 105 105 13 22
POTASSIUM CHLORIDE 102 93 15 40
CRESTOR 101 100 16 16
CLOPIDOGREL 100 88 17 17
ADVAIR DISKUS 94 92 18 28
DIGOXIN 92 92 19 33
ATENOLOL 92 92 19 27
SERTRALINE HCL 90 90 21 61
CITALOPRAM HBR 88 81 22 112
LIDODERM 88 84 22 81
QUETIAPINE FUMARATE 86 77 24 116
LACTULOSE 85 83 25 109
DIVALPROEX SODIUM 81 81 26 101
ATORVASTATIN CALCIUM 81 72 26 6
GABAPENTIN 78 70 28 21
HYDROCHLOROTHIAZIDE 77 76 29 20
ESCITALOPRAM OXALATE 73 71 30 91
LISINOPRIL 72 67 31 12
LANTUS 68 63 32 82
IPRATROPIUM-ALBUTEROL 66 66 33 173
CARVEDILOL 62 62 34 14
ALENDRONATE SODIUM 61 61 35 54
NOVOLOG 61 58 35 156
METOPROLOL SUCCINATE 60 54 37 5
HYDROMORPHONE HCL 58 58 S2 38 209
MECLIZINE HCL 57 49 39 144
FINASTERIDE 56 56 40 37
TAMSULOSIN HCL 56 56 40 11
PRAVASTATIN SODIUM 55 42 42 35
DIOVAN 54 49 43 15
PRANDIN 52 52 44 181
OLANZAPINE 51 51 45 174
FAMOTIDINE 51 51 45 50
TRAMADOL HCL 50 30 47 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.